Relay Therapeutics Announces Clinical Data for Zovegalisib plus Atirmociclib Triplet Combination Supportive of Further Development in Frontline Metastatic Breast Cancer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. APGE
6. HOOD
7. DFTX
8. GOOGL
9. MU
10. IBM

Go back to Relay Therapeutics Announces Clinical Data for Zovegalisib plus Atirmociclib Triplet Combination Supportive of Further Development in Frontline Metastatic Breast Cancer
(NASDAQ: RLAY) Delayed: 17.28 +1.40 (8.82%)
Previous Close $15.88    52 Week High $ 
Open $16.14    52 Week Low $ 
Day High $17.50    P/E N/A 
Day Low $16.14    EPS $ 
Volume 4,414,523